Steven Cohen’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$132K Buy
+16,267
New +$105K ﹤0.01% 3597
2026
Q2
– Sell
-19,436
Closed -$58.3K – 4649
2026
Q1
$58.3K Sell
19,436
-185,764
-91% -$718K ﹤0.01% 3652
2025
Q4
$1.25M Buy
+205,200
New +$1.87M ﹤0.01% 2753
2025
Q3
– Sell
-136,380
Closed -$952K – 2745
2025
Q2
$952K Buy
+136,380
New +$829K ﹤0.01% 1577

Other funds holding XGN

Steven Cohen's XGN Position: Q3 2026 in Review

Steven Cohen opened a new position in Exagen (XGN) in Q3 2026: 16,267 shares worth $132K. The stake represents ﹤0.01% of the portfolio and ranks #3597 among its holdings. This is a return to the name: Steven Cohen previously reported a position in XGN as recently as Q1 2026.

Steven Cohen first reported a position in XGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.25M in Q4 2025. 78 funds tracked by Wall St. Rank hold XGN as of Q3 2026.

  • Steven Cohen held 16,267 shares of Exagen worth $132K as of Q3 2026.
  • Exagen was a new Steven Cohen position in Q3 2026.
  • Exagen made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3597 holding.
  • Steven Cohen first reported a position in Exagen in Q2 2025 and has held it in 4 quarters since.
  • Steven Cohen's Exagen position peaked at $1.25M in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Exagen as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.